Composition and methods for sanitization
The present technology relates to a novel sanitization method for chromatography media and supporting equipment comprising treatment with a sanitization/sterilization solution comprising acetic acid and hexylene glycol.
1 . A method for sanitizing or sterilizing chromatography media and/or supporting equipment, comprising contacting the chromatography media and/or supporting equipment with a sanitization or sterilization solution comprising acetic acid and hexylene glycol, wherein
the concentration of acetic acid is from about 40 mM to about 200 mM,
the concentration of hexylene glycol is from about 8% by volume to about 80% by volume, and
the pH of the sanitization or sterilization solution is ≤3.5.
2 . A method for eluting a target analyte bound to a chromatography media, comprising contacting the chromatography media with an elution buffer comprising acetic acid and hexylene glycol, wherein
the concentration of acetic acid is from about 40 mM to about 200 mM,
the concentration of hexylene glycol is from about 8% by volume to about 80% by volume, and
the pH of the elution buffer is ≤3.5.
3 . The method of claim 1 , wherein the concentration of acetic acid is about 65 mM.
4 . The method of claim 2 , wherein the concentration of acetic acid is about 65 mM.
5 . The method of claim 1 , wherein the method provides a more effective bacteria, spore, and/or mold inactivation or killing within 1 hour of treatment with the sanitization or sterilization solution as compared to sanitizing or sterilizing the chromatography media and/or supporting equipment with a sanitization or sterilization solution comprising sodium hydroxide.
6 . The method of claim 2 , wherein the method provides improved product yield and peak sharpness as compared to eluting the target analyte with an elution buffer comprising no glycol or 20% by volume ethylene glycol.
7 . The method of claim 1 , wherein the concentration of hexylene glycol is about 20% by volume.
8 . The method of claim 1 , wherein the chromatography media is an affinity chromatography media.
9 . The method of claim 8 , wherein the affinity chromatography media comprises an affinity ligand that is based on protein A, protein G, protein A/G, or protein L, or any variant thereof.
10 . The method of claim 9 , wherein the affinity ligand is based on native protein A, recombinant protein A, genetically engineered protein A, or artificial protein A.
11 . The method of claim 1 , wherein the pH of the sanitization or sterilization solution is from about 3.0 to about 3.5.
12 . The method of claim 11 , wherein the pH of the sanitization or sterilization solution is about 3.1.
13 . The method of claim 5 , wherein the bacteria, spore, and/or mold inactivation is achieved within 40 minutes of treatment with the sanitization or sterilization solution.
14 . The method of claim 1 , wherein the sanitization method is used in a process comprising steps toward the purification of a polypeptide.
15 . The method of claim 14 , wherein the polypeptide is an antibody or a recombinant enzyme.
16 . The method of claim 15 , wherein the antibody is a monoclonal antibody.
17 . The method of claim 15 , wherein the recombinant enzyme is a human recombinant enzyme.
18 . The method of claim 15 , wherein the recombinant enzyme is a lysosomal glycogen-specific enzyme, a human enzyme acid α-glucosidase (GAA), avalglucosidase alfa or alglucosidase alfa.
19 . A method of increasing the lifetime of a chromatography media, comprising sanitizing or sterilizing the chromatography media with a solution comprising about 65 mM acetic acid and about 20% by volume hexylene glycol, wherein the method allows the lifetime of the chromatography media to be increased by at least about 10% as compared to sanitizing or sterilizing the chromatography media with at least one of: (i) gamma irradiation or (ii) a buffer comprising sodium hydroxide.
20 . The method of claim 19 , wherein the chromatography media comprises at least one of: an affinity resin, a resin that is based on protein A or a variant thereof, and a resin that is based on protein G or a variant thereof.
21 . The method of claim 19 , wherein the sanitizing or sterilizing comprises a step within an integrated continuous biomanufacturing process for purification of a polypeptide.